Qiagen NV
(NYSE:QGEN)
$
43.76
-0.39 (-0.88%)
Market Cap: 9.73 Bil
Enterprise Value: 10.24 Bil
PE Ratio: 137.61
PB Ratio: 2.86
GF Score: 87/100 
Qiagen NV at Evercore ISI HealthCONx Conference (Virtual) Transcript
Nov 29, 2022 / 02:15PM GMT
Release Date Price:
$50.39
(-0.41%)
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team
Okay. Thanks, everyone, for joining us this morning. Pleasure to have with us QIAGEN. We have the CFO, Roland Sackers. And I think from Investor Relations, we have Phoebe Loh. For some reason, John Gilardi is not with us, but hi to John, he's listening remotely. So with that, Roland, thanks for spending the time with us this morning.
Roland Sackers
Qiagen N.V. - CFO, MD & Member of Management Board
Yes, thanks, (inaudible) Vijay.
Questions & Answers
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team
So it's been a while since I've looked at the story closely. But I was just at a high level, Roland, the base business, I mean, this has been on a tear, right? That's growing at a teens rate -- when I go
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers